Integral Health Asset Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 96 |
|
|
2025
Q1 | – | Sell |
-150,000
| Closed | -$6.04M | – | 104 |
|
|
2024
Q4 | $6.04M | Buy |
+150,000
| New | +$6.04M | 0.51% | 55 |
|
|
2024
Q3 | – | Sell |
-250,000
| Closed | -$13.3M | – | 98 |
|
|
2024
Q2 | $13.3M | Sell |
250,000
-200,000
| -44% | -$10.6M | 1.26% | 25 |
|
|
2024
Q1 | $36.9M | Sell |
450,000
-50,000
| -10% | -$4.1M | 3.43% | 3 |
|
|
2023
Q4 | $9.31M | Sell |
500,000
-300,000
| -38% | -$5.58M | 1.27% | 35 |
|
|
2023
Q3 | $8.86M | Buy |
800,000
+70,000
| +10% | +$775K | 1.23% | 32 |
|
|
2023
Q2 | $11.8M | Buy |
730,000
+2,900
| +0.4% | +$47K | 1.47% | 27 |
|
|
2023
Q1 | $12.1M | Buy |
727,100
+127,100
| +21% | +$2.12M | 2.44% | 8 |
|
|
2022
Q4 | $5.64M | Buy |
+600,000
| New | +$5.64M | 1.18% | 31 |
|